AGP Executive Report
Last update: 6 hours agoFood Safety: FSSAI has questioned health claims on infant formulas and children’s products from Nestlé, Zydus Wellness and Abbott, including Complan’s “2X growth” claim, and sought scientific support. Air Quality: Delhi’s AQI crossed 200 after Dussehra, prompting Stage 1 GRAP curbs as pollution worsens. Medical Training: Jammu and Kashmir has more than doubled MBBS and BDS interns’ monthly stipend to ₹25,000, effective October 1; interns have called off their strike. Cancer Care: India will cut prices of 137 cancer medicines by up to 70% from November 9, a major potential relief for patients facing high treatment costs.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.